Steel Factor Responsiveness Regulates the High Self-renewal Phenotype of Fetal Hematopoietic Stem Cells
Overview
Affiliations
Fetal hematopoietic stem cells (HSCs) regenerate daughter HSCs in irradiated recipients more rapidly than do adult HSCs. However, both types of HSCs divide in vitro with the same cell-cycle transit times, suggesting different intrinsically determined self-renewal activities. To investigate the mechanism(s) underlying these differences, we compared fetal and adult HSC responses to Steel factor (SF) stimulation in vitro and in vivo. These experiments were undertaken with both wild-type cells and W(41)/W(41) cells, which have a functionally deficient c-kit kinase. In vitro, fetal HSC self-renewal divisions, like those of adult HSCs, were found to be strongly dependent on c-kit activation, but the fetal HSCs responded to much lower SF concentrations in spite of indistinguishable levels of c-kit expression. Fetal W(41)/W(41) HSCs also mimicked adult wild-type HSCs in showing the same reduced rate of amplification in irradiated adult hosts (relative to fetal wild-type HSCs). Assessment of various proliferation and signaling gene transcripts in fetal and adult HSCs self-renewing in vitro revealed a singular difference in Ink4c expression. We conclude that the ability of fetal HSCs to execute symmetric self-renewal divisions more efficiently than adult HSCs in vivo may be dependent on specific developmentally regulated signals that act downstream of the c-kit kinase.
Effect of bone marrow niche on hematopoietic stem cells.
Niazi V, Ghafouri-Fard S Histochem Cell Biol. 2024; 163(1):19.
PMID: 39714560 DOI: 10.1007/s00418-024-02348-z.
Xiong M, Xiu Y, Long J, Zhao X, Wang Q, Yang H Stem Cell Res Ther. 2024; 15(1):303.
PMID: 39278906 PMC: 11403967. DOI: 10.1186/s13287-024-03930-x.
Lessons from early life: understanding development to expand stem cells and treat cancers.
Bain F, Che J, Jassinskaja M, Kent D Development. 2022; 149(20).
PMID: 36217963 PMC: 9724165. DOI: 10.1242/dev.201070.
Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia.
Katagiri S, Chi S, Minami Y, Fukushima K, Shibayama H, Hosono N Int J Mol Sci. 2022; 23(9).
PMID: 35563085 PMC: 9103326. DOI: 10.3390/ijms23094694.
Mayer I, Hoelbl-Kovacic A, Sexl V, Doma E Cancers (Basel). 2022; 14(7).
PMID: 35406494 PMC: 8996967. DOI: 10.3390/cancers14071723.